CareDx, Inc
CareDx, Inc (CDNA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CDNA · as of Jun 8, 2026
Key Statistics
Explore CareDx, Inc Data
cdna stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 76.9%
The CDNA analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $24.00, representing +8.74% upside from the current price of $22.07.
Competitors & Peers
cdna competitorsCDNA
CRMD
CSTL
DRIO
EMBC
EVHStock Performance
Full HistoryAbout CareDx, Inc
CareDx, Inc discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) soluti…
what is caredx, inc · cdna stock overview · caredx, inc company profile · who is caredx, inc ceo · cdna NASDAQ · caredx, inc headquarters · caredx, inc business segments
About Stock Overview & Key Data
CareDx, Inc (CDNA) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 17, 2014. As of the latest trading session, CDNA stock price is $22.07, with a market capitalization of $1.1B. The stock has returned +13.14% over the past 12 months and +18.43% year-to-date.
According to 13 Wall Street analysts, the consensus rating for CareDx, Inc stock is Buy, with an average 12-month price target of $24.00. In fiscal year 2025, CareDx, Inc reported revenue of $379.8M and net income of -$21.4M. For detailed data — including CareDx, Inc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CareDx, Inc (CDNA) stock price is $22.07. The stock is traded on NASDAQ under the ticker symbol CDNA. The 52-week range is $10.96 – $23.24.